Events
Akari Therapeutics, Plc, a biopharmaceutical company focused on innovative therapeutics to treat orphan autoimmune and inflammatory diseases where the complement and/or leukotriene systems are implicated, announced an oral presentation will be given at the 28th EADV Congress.
Catalyst Pharmaceuticals, Inc. announced that it will release second quarter 2019 financial result after market close on Wednesday, August 7, 2019.
Medigene AG announced its participation at the following upcoming investor conferences:
MorphoSys AG will publish its first six months’ 2019 results on August 6, 2019 at 10:00pm CEST.
Presentation Made at the 10th International AIDS Society Conference on HIV Science
SGX-listed Singapore eDevelopment Ltd is pleased to announce the results of clinical trials conducted on Laetose, a low-glycemic, naturally modified sugar, developed by its U.S. biomedical subsidiary Global BioLife Inc..
Retrophin, Inc. announced it will report second quarter 2019 financial results on Tuesday, August 6, 2019 after the close of the U.S. financial markets.
In the early 1980s, Genentech produced the first biotech drug – insulin.
JADAK, a business unit of Novanta Corporation will be attending the 71st AACC Annual Scientific Meeting & Clinical Lab Expo at the Anaheim Convention Center August 6-8 in Booth #804.
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company focused on the development of novel products for serious rare and ultra-rare genetic diseases, announced that it will host a conference call on Thursday, August 1, 2019 at 5pm ET to discuss second quarter 2019 financial results and provide a corporate update.
PRESS RELEASES